Physician profile
Michael J Axe
NPI 1578534558
$120,328.98
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $25K · 2021: $59K · 2022: $6,293 · 2023: $5,866 · 2024: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $876 · Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,491.00 |
| Travel and Lodging | $875.60 |
| Food and Beverage | $579.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $93,590.62 | 2019-2021 | |
| Convatec INC. | $19,791.72 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $6,195.55 | 2022 | |
| Horizon Therapeutics Plc | $220.79 | 2019-2020 | |
| Arthrex, INC. | $208.88 | 2022-2023 | Arthrex |
| Smith+Nephew, INC. | $124.03 | 2019-2021 | |
| Depuy Synthes Sales INC. | $105.54 | 2019-2023 | Monovisc |
| Liberty Surgical INC. | $52.67 | 2020 | |
| Triad Life Sciences INC. | $26.42 | 2022 | |
| Wright Medical Technology, INC. | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Axe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.